1. Gust D, Strine T, Maurice E, Smith P, Yusuf H, Wilkinson M, et al. Under immunization among children: effects of vaccine safety concerns on immunization status. Pediatrics. 2004;114(1):e16–22.
2. Hall SN. The design and analysis of pediatric vaccine formularies: theory and practice [online] [PhD dissertation]. Champaign: University of Illinois; 2006. a462462.pdf (dtic.mil). Accessed 19 November 2021
3. Orsi A, Azzari C, Bozzola E, Chiamenti G, Chirico G, Esposito S, et al. Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts. J Prev Med Hyg. 2018;59(2):E107–9.
4. Reportlinker. A white paper to understand the market structure of pediatric pertussis combination vaccines. 2020. https://www.reportlinker.com/insight/wp-content/uploads/2020/11/201113_Market-study_on_Hexavalent_Vaccine_White_Paper.pdf?utm_medium=blog&utm_source=insight&utm_campaign=Sanofi2020&utm_content=report. Accessed 19 November 2021.
5. Reinert P, Boucher J, Pines E, Leroux MC, Hoffenbach A, Salomon H, et al. Primary or booster immunization with DTaP–IPV vaccine administered either in combination or in association with Haemophilus influenzae type b vaccine (act-Hib): a large-scale safety study. Paris: Programs and Abstracts of the 15th Annual Meeting of the European Society for Paediatric Infectious Diseases; 1997.